Ophthalmic Anesthetics
Key Points
- Topical ocular anesthetics are used for short eye procedures, not routine at-home pain control.
- Class effect is sodium-channel blockade that temporarily interrupts ocular sensory impulse conduction.
- Prolonged use or misuse can cause corneal epithelial toxicity, corneal opacity, and permanent vision loss.
- Proparacaine usually has rapid onset and short duration; tetracaine has slower onset and longer duration.
- Clients must avoid touching a numb eye and should not ambulate independently if vision is unclear.
Class Overview
Ophthalmic anesthetics temporarily block sodium ion channels in ocular nerve tissue, preventing action-potential initiation and propagation. The result is local corneal and conjunctival anesthesia for examination and minor procedural care.
Typical indications include tonometry, corneal foreign-body removal, corneal suturing support, conjunctival scraping, laser refractive procedures, and selected glaucoma-focused diagnostic examinations.
Common Agents and Typical Dosing
| Drug | Typical Adult Ophthalmic Dosing Pattern | Notes |
|---|---|---|
| Proparacaine 0.5% | 1-2 drops before procedure; short corneal/conjunctival procedures may use repeat dosing every 5-10 minutes for 5-7 doses | Rapid onset, short duration |
| Tetracaine 0.5% or 1% | 1-2 drops as needed; repeat frequency depends on procedure duration (for example every 5-10 minutes for selected longer procedures) | Slower onset, longer duration |
Adverse Effects and Contraindications
- Transient stinging, burning, conjunctival redness, ocular discomfort
- Corneal epithelial toxicity and corneal opacity with prolonged or inappropriate use
- Vision loss risk when corneal injury progresses
- Rare severe immediate hyperallergic corneal reaction reported with proparacaine (diffuse keratitis pattern, necrotic epithelial sloughing, iritis/descemet membrane inflammation)
- Contraindication: hypersensitivity to product ingredients
Nursing Assessment and Interventions
- Complete preprocedure assessment, including allergy history, cardiopulmonary context, anticoagulant use, prior ocular-procedure history, and mobility/fall risk.
- Reassess pain and vision as anesthetic effect wears off.
- Keep environment uncluttered with adequate lighting to reduce injury risk while depth/clarity perception is altered.
- Reinforce no-touch eye protection while numbness persists.
- Escalate progressive vision deterioration, persistent ocular pain, or severe inflammatory findings immediately.
Client Education
- Do not touch, rub, or press on the anesthetized eye.
- Ask for assistance with ambulation if vision is unclear.
- Report worsening pain, vision changes, or persistent redness promptly.
- Follow procedure-specific instructions for post-anesthesia eye protection.
Related Concepts
- ophthalmic-medication-administration - No-touch instillation and route-specific safety.
- ophthalmic-lubricants - Ocular-surface protection after procedures when dryness/exposure symptoms occur.
- eye-assessment-visual-acuity-and-common-abnormalities - Baseline and follow-up visual monitoring.
- falls - Altered visual perception can increase immediate post-instillation fall risk.